Published April 3, 2024 | Version v1
Journal article

A Potent Solution for Tumor Growth and Angiogenesis Suppression via an ELR + CXCL-CXCR1/2 Pathway Inhibitor

Description

International audience

Additional details

Created:
January 13, 2025
Modified:
January 13, 2025